Uncategorized

  Download: A Review of the Notice of Proposed Rulemaking (NPRM) Changes to the Common Rule, David Vulcano

On Thursday, September 17, 2015, the United States Senate Subcommittee on Primary Health and Retirement Security held a hearing on…

One of the only major bipartisan moments in recent Congressional history is the physician-backed repeal of the…

Last week, MedPAC (the Medicare Payments Advisory Commission), an important advisory committee to congress, held their…

Life science companies continue to face a number of challenges in today’s business climate. M&A activity, economic trends, and…

Last week, Genzyme Corporation, a wholly-owned subsidiary of the French company Sanofi, agreed to pay $32.5 million to…

Today, the Department of Health and Human Services (HHS) along with 15 other federal agencies and departments officially…

The August issue of Life Science Compliance Update provides an interesting look at the recently released 2014 Open…

Gilead’s Hepatitis C drugs Sovaldi and Harvoni are often targeted for their upfront price, rather than their long-term benefits…

On July 20, Abraham Gitterman of Arnold & Porter LLP joined Mark Linver and Paul Silver of Huron Life Sciences to discuss…